Global De-identified Health Data Market Size, Share, and COVID-19 Impact Analysis, By Type (Clinical Data, Genomic Data, Patient Demographics, Prescription Data, Hospital and Provider Data, and Pharmacogenomic Data), By Application (Clinical Research and Trials, Public Health, Precision Medicine, Health Economics and Outcomes Research (HEOR), Population Health Management, and Drug Discovery and Development), By End-user (Pharmaceutical Companies, Biotechnology Firms, Medical Device Manufacturers, Healthcare Providers, Insurance Companies/ Healthcare Payers, Government Agencies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033
Premium Report Details
Base Year:
2023
Tables & Figures:
95
Pages:
220
Countries covered:
17
Companies covered::
19
Forecast CAGR:
8.57%
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies